Raouf H E, Yassin A S, Megahed S A, Ashour M S, Mansour T M
Department of Microbiology and Immunology, Faculty of Pharmacy, Modern Sciences and Arts University, Giza, Egypt.
J Viral Hepat. 2015 Feb;22(2):103-11. doi: 10.1111/jvh.12260. Epub 2014 Apr 23.
Occult hepatitis B infection is characterized by the presence of hepatitis B virus (HBV) DNA in the serum in the absence of hepatitis B surface antigen (HBsAg). Prevalence of hepatitis C virus (HCV) infections in Egypt is among the highest in the world. In this study, we aim at analysing the rates of occult HBV infections among HCV paediatric cancer patients in Egypt. The prevalence of occult HBV was assessed in two groups of paediatric cancer patients (HCV positive and HCV negative), in addition to a third group of paediatric noncancer patients, which was used as a general control. All groups were negative for HBsAg and positive for HCV antibody. HBV DNA was detected by nested PCR and real-time PCR. HCV was detected by real-time PCR. Sequencing was carried out in order to determine HBV genotypes to all HBV patients as well as to detect any mutation that might be responsible for the occult phenotype. Occult hepatitis B infection was observed in neither the non-HCV paediatric cancer patients nor the paediatric noncancer patients but was found in 31% of the HCV-positive paediatric cancer patients. All the detected HBV patients belonged to HBV genotype D, and mutations were found in the surface genome of HBV leading to occult HBV. Occult HBV infection seems to be relatively frequent in HCV-positive paediatric cancer patients, indicating that HBsAg negativity is not sufficient to completely exclude HBV infection. These findings emphasize the importance of considering occult HBV infection in HCV-positive paediatric cancer patients especially in endemic areas as Egypt.
隐匿性乙型肝炎感染的特征是血清中存在乙型肝炎病毒(HBV)DNA,但不存在乙型肝炎表面抗原(HBsAg)。埃及丙型肝炎病毒(HCV)感染的患病率位居世界前列。在本研究中,我们旨在分析埃及HCV阳性儿童癌症患者中隐匿性HBV感染的发生率。除了第三组儿科非癌症患者作为一般对照外,还在两组儿科癌症患者(HCV阳性和HCV阴性)中评估了隐匿性HBV的患病率。所有组HBsAg均为阴性,HCV抗体均为阳性。通过巢式PCR和实时PCR检测HBV DNA。通过实时PCR检测HCV。进行测序以确定所有HBV患者的HBV基因型,并检测可能导致隐匿表型的任何突变。在非HCV儿科癌症患者和儿科非癌症患者中均未观察到隐匿性乙型肝炎感染,但在31%的HCV阳性儿科癌症患者中发现了隐匿性乙型肝炎感染。所有检测到的HBV患者均属于HBV D基因型,并且在HBV表面基因组中发现了导致隐匿性HBV的突变。隐匿性HBV感染在HCV阳性儿科癌症患者中似乎相对常见,这表明HBsAg阴性不足以完全排除HBV感染。这些发现强调了在HCV阳性儿科癌症患者中,尤其是在埃及这样的流行地区,考虑隐匿性HBV感染的重要性。